We also dive into the significance of the first-ever professional practice guidelines for psychedelic-assisted therapy co-published by APPA and BrainFutures. These guidelines are shaping the future of psychedelic therapy and ensuring its safety and effectiveness.
Advocates have raised concerns about ballot measures filed in Massachusetts by a Washington-D.C. based super PAC, “New Approaches,” that would create a strictly regulated framework for use.
Boo! Did we catch you off guard? Good, because this…
Explore how Wiz Khalifa is diversifying his portfolio from hip-hop and cannabis to the burgeoning world of mushroom products, and what this could mean for the future of psychedelic legalization.
A survey of 170 volunteers found chronic pain was relieved by both macro- and microdoses of classic psychedelics, including LSD and psilocybin.
In recent years, the mental health and cognitive benefits of…
California stands on the cusp of a psychedelic revolution with the TREAT Act and a landmark bill on ‘magic mushrooms,’ even as Michigan, Congress, and global initiatives from Sweden to Canada expand the horizons of mental health, addiction treatment, and veteran care.
“MDMA-assisted therapy for PTSD is on track to be considered for approval by the FDA in 2024,” says MAPS founder and president Rick Doblin.
Initial clinical trials into this exciting frontier have unveiled promising outcomes, showcasing remarkable improvements in clinical results using anti-inflammatory, nanoliposomal products prior to the application of a psychedelic agent.
State senators are calling on U.S. Congress officials overseeing veteran care to “prioritize research and investment” into psychedelics and other mental health treatment techniques that could reduce suicides.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.